Ameriprise Financial Inc Arcutis Biotherapeutics, Inc. Transaction History

Ameriprise Financial Inc

  • $358 Billion
  • Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 93,940 shares of ARQT stock, worth $873,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93,940
Previous 1,079,580 91.3%
Holding current value
$873,642
Previous $3.49 Million 73.33%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$3.25 - $11.77 $3.2 Million - $11.6 Million
-985,640 Reduced 91.3%
93,940 $930,000
Q4 2023

Feb 14, 2024
BUY
$1.84 - $4.82 $1.99 Million - $5.2 Million
1,079,580 New
1,079,580 $3.49 Million
Q2 2023

Aug 14, 2023
SELL
$7.51 - $15.0 $3.89 Million - $7.77 Million
-517,682 Reduced 60.57%
337,052 $3.21 Million
Q1 2023

May 15, 2023
BUY
$10.23 - $17.14 $420,575 - $704,659
41,112 Added 5.05%
854,734 $9.4 Million
Q4 2022

Feb 14, 2023
BUY
$13.96 - $20.4 $2.22 Million - $3.24 Million
158,944 Added 24.28%
813,622 $12 Million
Q3 2022

Nov 14, 2022
BUY
$17.85 - $26.95 $1.97 Million - $2.98 Million
110,490 Added 20.3%
654,678 $12.5 Million
Q2 2022

Aug 15, 2022
BUY
$16.33 - $22.2 $1.86 Million - $2.53 Million
113,926 Added 26.48%
544,188 $11.6 Million
Q1 2022

May 16, 2022
BUY
$14.38 - $22.79 $3.08 Million - $4.87 Million
213,859 Added 98.82%
430,262 $8.29 Million
Q4 2021

Feb 14, 2022
SELL
$14.98 - $25.5 $2.18 Million - $3.71 Million
-145,632 Reduced 40.23%
216,403 $4.49 Million
Q3 2021

Nov 15, 2021
BUY
$19.28 - $27.1 $137,948 - $193,900
7,155 Added 2.02%
362,035 $8.66 Million
Q2 2021

Aug 16, 2021
BUY
$24.42 - $34.75 $920,072 - $1.31 Million
37,677 Added 11.88%
354,880 $9.69 Million
Q1 2021

May 17, 2021
BUY
$24.47 - $36.98 $4.95 Million - $7.47 Million
202,086 Added 175.55%
317,203 $9.18 Million
Q4 2020

Feb 12, 2021
SELL
$17.82 - $31.73 $3.02 Million - $5.37 Million
-169,329 Reduced 59.53%
115,117 $3.24 Million
Q3 2020

Nov 16, 2020
BUY
$23.44 - $32.28 $150,648 - $207,463
6,427 Added 2.31%
284,446 $8.33 Million
Q2 2020

Aug 14, 2020
BUY
$24.48 - $36.56 $577,238 - $862,084
23,580 Added 9.27%
278,019 $8.41 Million
Q1 2020

May 15, 2020
BUY
$18.5 - $36.9 $4.71 Million - $9.39 Million
254,439 New
254,439 $7.58 Million

Others Institutions Holding ARQT

# of Institutions
172
Shares Held
126M
Call Options Held
498K
Put Options Held
1.64M
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $560M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email